Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-TAK1 is a serine/threonine-protein kinase that regulates cell cycle progression by phosphorylating Cdc25C on serine 216. This phosphorylation event mediates binding of the 14-3-3 protein, sequestering Cdc25C in the cytoplasm during interphase and preventing premature entry into mitosis. Unlike Chk1, C-TAK1 appears to function independently under normal conditions. Dysregulation could potentially contribute to aberrant cell cycle control, a hallmark of cancer.
Phosphorylation of Cdc25C on serine 216, leading to 14-3-3 binding and cytoplasmic sequestration
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cdc25C-associated protein kinase 1 (C-TAK1).